July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Comparative Evaluation of Typical and Atypical Pterygia Using Stem Cell and Germ Cell Markers
Author Affiliations & Notes
  • Rebecca Weiss
    Montefiore Medical Center, New York, United States
  • Maria Abadi
    Jacobi Medical Center, New York, United States
  • Alexandra Herzlich
    Jacobi Medical Center, New York, United States
  • Takayuki Nagasaki
    Columbia University, New York, United States
    Jacobi Medical Center, New York, United States
  • Footnotes
    Commercial Relationships   Rebecca Weiss, None; Maria Abadi, None; Alexandra Herzlich, None; Takayuki Nagasaki, None; JOYCE MBEKEANI, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6254. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rebecca Weiss, Maria Abadi, Alexandra Herzlich, Takayuki Nagasaki, JOYCE MBEKEANI; Comparative Evaluation of Typical and Atypical Pterygia Using Stem Cell and Germ Cell Markers. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6254.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Pterygia are common, benign ocular surface growths; however, studies have shown a small proportion of pterygia display atypical histologic features. In a previous study, we observed squamous dysplasia and choristomas in a minority of pterygium specimens. We sought to investigate the expression of stem cell and germ cell markers in these atypical pterygia compared to typical pterygium specimens in order to gain more insight into the pathophysiology of pterygia and possible association with premalignancy.

Methods : We performed a retrospective chart review to identify cases of atypical pterygium histopathology and compared them to age-matched typical pterygium histopathology from January 2000 to December 2015. All preserved specimens were stained with the stem cell markers p63 and CK19 as well as the germ cell marker OCT3/4. Staining patterns were analyzed by a single pathologist.

Results : Seven atypical pterygium specimens were identified: two with squamous dysplasia and five with simple and complex choristomas. The choristomas were comprised of cartilaginous, adipose, glandular and nervous tissue. We found diffuse p63 staining of conjunctival basal and suprabasal epithelial cells, but only focal staining of corneal epithelium within typical pterygium specimens. Squamous atypia/dysplasia associated with pterygia demonstrated strong, diffuse, full thickness staining of the epithelium with p63. Mesenchymal (cartilage, adipose tissue) and glandular choristomas did not express p63. In both typical and atypical specimens, CK19 was expressed in the conjunctival epithelium but not within the advancing epithelial edge of the pterygium that grows onto the cornea. Choristomas of mesenchymal origin did not express CK19 while those of epithelial origin, such as glandular tissue, did express CK19 in the same pattern as the surface epithelium of typical pterygia. OCT3/4 was variably expressed in typical and atypical conjunctival epithelium and stroma and displayed marked staining within the epithelium and stroma of atypical pterygia associated with mesenchymal choristomas.

Conclusions : Strong p63 and CK19 immunoreactivity within pterygium specimens may suggest that pterygia arise from limbal stem cell progenitors. Strong OCT3/4 expression in atypical pterygia associated with mesenchymal choristomas suggests a primitive state of pluripotency and may therefore predispose to recurrence and potential for malignancy.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.



This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.